9 WORLD GASTROENTEROLOGY NEWS JANUARY 2016 Gastro 2015: AGW-WGO | Expert Point of View | Gastro 2016: EGHS-WGO | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events 2. Perez-Cobas AE., Gosalbes MJ., Friedrichs A., Knecht H., Artacho A., Eismann K., et al. Gut micro-biota disturbance during antibiotic therapy: a multi-omic approach. Gut 2013;62(11):1591–601. 3. Ungaro R., Bernstein CN., Gearry R., Hviid A., Kolho K-L., Kronman MP., et al. Antibiot-ics associated with increased risk of new-onset Crohn’s dis-ease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol 2014;109(11):1728–38. 4. Hviid A., Svanström H., Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011;60(1):49–54. 5. Virta L., Auvinen A., Helenius H., Huovinen P., Kolho KL. As-sociation of repeated exposure to antibiotics with the development of pediatric crohn’s disease - A nationwide, register-based Finnish case-control study. Am J Epidemiol 2012;175(8):775–84. 6. Goto Y, Kurashima Y, Ki-yono H. The gut microbiota and inflammatory bowel dis-ease. Curr Opin Rheumatol. 2015;27:388-96. doi: 10.1097/ BOR.0000000000000192. 7. Frank DN St, Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780–13785. 8. Varela E, Manichanh C, Gal-lart M, Torrejón A, Borruel N, Casellas F, Guarner F, Antolin M. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Phar-macol Ther. 2013;38:151-61. doi: 10.1111/apt.12365. 9. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489–99. 10. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intes-tinal microbiome in inflamma-tory bowel disease and treatment. Genome Biol. 2012;13:R79. 11. Chehoud C, Albenberg LG, Judge C, Hoffmann C, Grun-berg S, Bittinger K, Baldassano RN, Lewis JD, Bushman FD, Wu GD. Fungal Signature in the Gut Microbiota of Pediat-ric Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:1948-56. doi: 10.1097/ MIB.0000000000000454. 12. Machiels K, Sabino J, Vander-mosten L, Joossens M, Arijs I, de Bruyn M, Eeckhaut V, Van Assche G, Ferrante M, Verhaegen J, Van Steen K, Van Immerseel F, Huys G, Verbeke K, Wolthuis A, de Buck Van Overstraeten A, D’Hoore A, Rutgeerts P, Vermeire S. Specific members of the pre-dominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut. 2015: 30. pii: gutjnl-2015-309398. doi: 10.1136/gutjnl-2015-309398. 13. Putignani L, Del Chierico F, Vernocchi P, Cicala M, Cucchiara S, Dallapiccola B; Dysbiotrack Study Group. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition. Inflamm Bowel Dis. 2015 Oct 21. Epub ahead of print PubMed PMID: 26588090. 14. Shah ND, Parian AM, Mullin GE, Limketkai BN. Oral Diets and Nutrition Support for Inflam-matory Bowel Disease: What Is the Evidence? Nutr Clin Pract. 2015;30: 462-73.
ewgn-vol20-issue4-FINAL
To see the actual publication please follow the link above